Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127587871 | 12758787 | 1 | I | 20160906 | 20160919 | 20160919 | EXP | US-CORDEN PHARMA LATINA S.P.A.-US-2016COR000206 | CORDEN | KOTHARI S, UD-DIN N, LISI M, COYLE T.. CRIZOTINIB IN ANAPLASTIC LYMPHOMA KINASE-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA IN THE SETTING OF RENAL INSUFFICIENCY: A CASE REPORT.. J MED CASE REP. 2016;10:176 | 48.00 | YR | M | Y | 0.00000 | 20160919 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127587871 | 12758787 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | UNK, [THREE CYCLES] | D | 19880 | ||||||||||
| 127587871 | 12758787 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | UNK, [THREE CYCLES] | D | 0 | ||||||||||
| 127587871 | 12758787 | 3 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | UNK, [THREE CYCLES] | D | 0 | ||||||||||
| 127587871 | 12758787 | 4 | SS | CRIZOTINIB | CRIZOTINIB | 1 | 250 MG, BID | D | 0 | 250 | MG | ||||||||
| 127587871 | 12758787 | 5 | SS | CRIZOTINIB | CRIZOTINIB | 1 | Oral | 250 MG, QD | D | 0 | 250 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127587871 | 12758787 | 1 | Anaplastic large cell lymphoma T- and null-cell types stage IV |
| 127587871 | 12758787 | 2 | Anaplastic large cell lymphoma T- and null-cell types stage IV |
| 127587871 | 12758787 | 3 | Anaplastic large cell lymphoma T- and null-cell types stage IV |
| 127587871 | 12758787 | 4 | Anaplastic large cell lymphoma T- and null-cell types stage IV |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127587871 | 12758787 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127587871 | 12758787 | Lymphadenopathy | |
| 127587871 | 12758787 | Pyrexia | |
| 127587871 | 12758787 | Renal failure | |
| 127587871 | 12758787 | Tubulointerstitial nephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |